505 related articles for article (PubMed ID: 24996775)
1. Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff.
Pignot G; Bigot P; Bernhard JC; Bouliere F; Bessede T; Bensalah K; Salomon L; Mottet N; Bellec L; Soulié M; Ferrière JM; Pfister C; Drai J; Colombel M; Villers A; Rigaud J; Bouchot O; Montorsi F; Bertini R; Belldegrun AS; Pantuck AJ; Patard JJ
Urol Oncol; 2014 Oct; 32(7):1024-30. PubMed ID: 24996775
[TBL] [Abstract][Full Text] [Related]
2. [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].
Boulière F; Crepel M; Bigot P; Pignot G; Bessede T; de la Taille A; Salomon L; Tostain J; Bellec L; Soulié M; Rischmann P; Bernhard JC; Ferrière JM; Pfister C; Albouy B; Colombel M; Zini L; Villers A; Rigaud J; Bouchot O; Patard JJ
Prog Urol; 2011 Nov; 21(12):842-50. PubMed ID: 22035910
[TBL] [Abstract][Full Text] [Related]
3. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
4. Can partial nephrectomy preserve renal function and modify survival in comparison with radical nephrectomy?
Medina-Polo J; Romero-Otero J; Rodríguez-Antolín A; Domínguez-Esteban M; Passas-Martínez J; Villacampa-Aubá F; Lora-Pablos D; Gómez De La Cámara A; Díaz-González R
Scand J Urol Nephrol; 2011 Mar; 45(2):143-50. PubMed ID: 21247272
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm.
Roos FC; Brenner W; Thomas C; Jäger W; Thüroff JW; Hampel C; Jones J
Urology; 2012 Mar; 79(3):607-13. PubMed ID: 22386408
[TBL] [Abstract][Full Text] [Related]
6. Impact of renal surgery for cortical neoplasms on lipid metabolism.
Bagrodia A; Kopp RP; Mehrazin R; Lee HJ; Liss MA; Jabaji R; Kane CJ; Wake RW; Patterson AL; Wan JY; Derweesh IH
BJU Int; 2014 Dec; 114(6):837-43. PubMed ID: 24656182
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors.
Jeon HG; Jeong IG; Lee JW; Lee SE; Lee E
Urology; 2009 Nov; 74(5):1064-8. PubMed ID: 19758688
[TBL] [Abstract][Full Text] [Related]
8. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
[TBL] [Abstract][Full Text] [Related]
9. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
10. Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes.
Bigot P; Hétet JF; Bernhard JC; Fardoun T; Audenet F; Xylinas E; Ploussard G; Pignot G; Bessede T; Ouzaid I; Robine E; Brureau L; Merigot de Treigny O; Maurin C; Long JA; Rouffilange J; Hoarau N; Lebdai S; Rouprêt M; Bastien L; Neuzillet Y; Mongiat-Artus P; Verhoest G; Zerbib M; Ravery V; Rigaud J; Bellec L; Baumert H; Chautard D; Bensalah K; Escudier B; Paparel P; Grenier N; Rioux-Leclercq N; Azzouzi AR; Soulié M; Patard JJ
Clin Genitourin Cancer; 2014 Feb; 12(1):e19-27. PubMed ID: 24210610
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcome of Nephron-Sparing Surgery Compared to Radical Nephrectomy for Renal Cell Carcinoma ≥4 cm - A Matched-Pair Single Institution Analysis.
Kalogirou C; Fender H; Muck P; Hey V; Krebs M; Riedmiller H; Vergho D
Urol Int; 2017; 98(2):138-147. PubMed ID: 27505105
[TBL] [Abstract][Full Text] [Related]
12. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
14. Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.
Takagi T; Kondo T; Iizuka J; Kobayashi H; Hashimoto Y; Nakazawa H; Ito F; Tanabe K
Int J Urol; 2011 Jun; 18(6):472-6. PubMed ID: 21481013
[TBL] [Abstract][Full Text] [Related]
15. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
16. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
17. Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors.
Yoo S; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H; Song C
J Korean Med Sci; 2017 Mar; 32(3):495-501. PubMed ID: 28145654
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
[TBL] [Abstract][Full Text] [Related]
19. [Long-term renal function in patients with renal-cell carcinoma treated surgically: comparison between radical and partial nephrectomy].
López-Garibay LA; Cendejas-Gómez Jde J; Rodríguez-Covarrubias F; Gómez-Conzatti A; Gabilondo-Navarro F; Sotomayor-de-Zavaleta M
Rev Invest Clin; 2013; 65(1):7-11. PubMed ID: 23745439
[TBL] [Abstract][Full Text] [Related]
20. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
